— Know what they know.
Not Investment Advice
Also trades as: EYE.AX (ASX) · $vol 0M

ELXMF OTC

Nova Eye Medical Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +653.2% 1Y: -85.7% 3Y: -85.7% 5Y: -94.5%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 48 · $4.1M mcap · 233M float · 0.0004% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$22M -18.7% ▼
5Y CAGR: -12.5%
Total Liabilities
$7M -3.1% ▼
5Y CAGR: +1.9%
Shareholders Equity
$14M -24.8% ▼
5Y CAGR: -16.6%
Cash & Investments
$963K -81.0% ▼
5Y CAGR: -44.2%
Total Debt
$2M -20.8% ▼
5Y CAGR: -8.4%
Net Debt
$1M +170.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$8M$7M$6M$5M$963K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$8M$7M$6M$5M$963K
Net Receivables$2M$2M$4M$4M$5M
Inventory$4M$4M$4M$3M$3M
Other Current Assets$2M$884K$0$94K$0
Total Current Assets$16M$15M$15M$12M$10M
Property, Plant & Equip.$3M$2M$4M$3M$3M
Goodwill & Intangibles$18M$13M$7M$7M$9M
Long-Term Investments$68K$71K$0$0$132K
Other Non-Current Assets-$10M-$11M$4M$4M$0
Total Non-Current Assets$21M$16M$15M$14M$12M
Total Assets$37M$30M$30M$27M$22M
— Liabilities —
Accounts Payable$2M$4M$4M$2M$2M
Short-Term Debt$0$0$0$0$610K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$5K$5K$0$0$0
Total Current Liabilities$4M$6M$6M$5M$6M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$966K$0$0$0$0
Total Non-Current Liabilities$2M$892K$3M$2M$2M
Total Liabilities$6M$7M$9M$8M$7M
— Equity —
Common Stock$37M$45M$53M$59M$59M
Retained Earnings-$7M-$22M-$31M-$40M-$44M
Accumulated OCI-$439K-$87K-$693K-$230K-$748K
Total Stockholders Equity$30M$23M$21M$19M$14M
Total Liabilities & Equity$37M$30M$30M$27M$22M
— Key Metrics —
Total Debt$2M$2M$3M$3M$2M
Net Debt-$6M-$6M-$3M-$2M$1M
Total Investments$68K$71K$0$0$132K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms